Kansas Patent of the Month – February 2025
Love Lifesciences INC has developed a groundbreaking auto-injector designed to address the key challenges associated with self-administered injections. This innovative device combines safety, ease of use, and patient comfort, making injections less intimidating and more accessible for those who rely on them for medical treatment.
Unlike traditional auto-injectors, which can startle users with an abrupt needle deployment, our injector features a retractable safety tube that shields the needle before and after use. This reduces needle phobia and minimizes accidental needle sticks. The device’s casing ensures the syringe barrel remains securely fixed, providing precise control over medication delivery. Additionally, a plunger slider allows for smooth and controlled injection, giving users confidence in the process.
The mechanism incorporates a biasing member that enables the safety tube to extend automatically after injection, effectively covering the needle. A locking mechanism prevents reuse, maintaining sterility and reducing contamination risks. This design not only improves patient compliance but also aligns with healthcare industry standards for safety and reliability.
By integrating pre-filled syringes, our injector streamlines medication administration, eliminating the need for manual syringe preparation. The casing also includes a viewing window, allowing users to confirm dosage delivery. With its intuitive operation and focus on patient safety, this device is set to redefine injectable therapy.
Love Lifesciences INC continues to push the boundaries of medical innovation, ensuring that life-saving treatments are delivered with precision, comfort, and security. This next-generation injector represents a crucial step in making injectable medications more user-friendly, ultimately improving adherence and health outcomes for patients worldwide.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
